Marta Reverte
Boudry, NE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Patient-Reported Outcomes With Luspatercept Through 5 Years of Treatment in Patients With Non-Transfusion-Dependent β-Thalassemia Treated in the BEYOND Trial.
Journal: European journal of haematology
Published: November 15, 2025
Achieving clinically meaningful changes in haemoglobin levels in patients with non-transfusion-dependent β-thalassaemia treated with luspatercept: A post hoc analysis of the phase 2 BEYOND trial.
Journal: British journal of haematology
Published: August 04, 2025
Dissection of the macrophage response towards infection by the Leishmania-viral endosymbiont duo and dynamics of the type I interferon response.
Journal: Frontiers in cellular and infection microbiology
Published: May 11, 2022
In and out: Leishmania metastasis by hijacking lymphatic system and migrating immune cells.
Journal: Frontiers in cellular and infection microbiology
Published: May 11, 2022
The Dangerous Liaisons in the Oxidative Stress Response to Leishmania Infection.
Journal: Pathogens (Basel, Switzerland)
Published: February 28, 2022
Trained Immunity Confers Prolonged Protection From Listeriosis.
Journal: Frontiers in immunology
Published: June 10, 2021
Leishmania Parasite Quantification by Bioluminescence in Murine Models.
Journal: Bio-protocol
Published: September 24, 2019
Mammalian Innate Immune Response to a Leishmania-Resident RNA Virus Increases Macrophage Survival to Promote Parasite Persistence.
Journal: Cell host & microbe
Published: February 09, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026